...
首页> 外文期刊>Journal of microbiology and biotechnology >Evaluation of macroporous and microporous carriers for CHO-K1 cell growth and monoclonal antibody production
【24h】

Evaluation of macroporous and microporous carriers for CHO-K1 cell growth and monoclonal antibody production

机译:大孔和微孔载体对CHO-K1细胞生长和单克隆抗体产生的评估

获取原文
获取原文并翻译 | 示例

摘要

The emergence of microcarrier technology has brought a renewed interest in anchorage-dependent cell culture for high-yield processes. Well-known in vaccine production, microcarrier culture also has potential for application in other fields. In this work, two types of microcarriers were evaluated for small-scale monoclonal antibody (mAb) production by CHO-K1 cells. Cultures (5 ml) of microporous Cytodex 3 and macroporous CultiSpher-S carriers were performed in vented conical tubes and subsequently scaled-up (20 ml) to shake-flasks, testing combinations of different culture conditions (cell concentration, microcarrier concentration, rocking methodology, rocking speed, and initial culture volume). Culture performance was evaluated by considering the mAb production and cell growth at the phases of initial adhesion and proliferation. The best culture performances were obtained with Cytodex 3, regarding cell proliferation (average 1.85 ± 0.11 × 10~6 cells/ml against 0.60 ± 0.08 × 106 cells/ ml for CultiSpher-S), mAb production (2.04 ± 0.41μg/ml against 0.99 ± 0.35 μg/ml for CultiSpher-S), and culture longevity (30 days against 10-15 days for CultiSpher-S), probably due to the collagen-coated dextran matrix that potentiates adhesion and prevents detachment. The culture conditions of greater influence were rocking mechanism (Cytodex 3, pulse followed by continuous) and initial cell concentration (CultiSpher-S, 4 × 105 cells/ml). Microcarriers proved to be a viable and favorable alternative to standard adherent and suspended cultures for mAb production by CHO-K1 cells, with simple operation, easy scale-up, and significantly higher levels of mAb production. However, variations of microcarrier culture performance in different vessels reiterate the need for optimization at each step of the scale-up process.
机译:微载体技术的出现使人们对高产量过程中依赖锚固的细胞培养产生了新的兴趣。微载体培养在疫苗生产中众所周知,在其他领域也具有应用潜力。在这项工作中,评估了两种类型的微载体对CHO-K1细胞产生的小规模单克隆抗体(mAb)的影响。微孔Cytodex 3和大孔CultiSpher-S载体的培养(5 ml)在通风的锥形管中进行,然后按比例放大(20 ml)到烧瓶中,测试不同培养条件的组合(细胞浓度,微载体浓度,摇动方法) ,摇摆速度和初始培养量)。通过在初始粘附和增殖阶段考虑mAb产生和细胞生长来评估培养性能。在细胞增殖方面,使用Cytodex 3可获得最佳的培养性能(CultiSpher-S平均为1.85±0.11×10〜6细胞/ ml,而CultiSpher-S为0.60±0.08×106细胞/ ml),mAb产生(相对于CultiSpher-S为2.04±0.41μg/ ml CultiSpher-S为0.99±0.35μg/ ml,培养寿命(CultiSpher-S为30天,而CultiSpher-S为10-15天),这可能是由于胶原蛋白包裹的葡聚糖基质增强了粘附力并防止了分离。影响最大的培养条件是摇动机制(Cytodex 3,脉冲,然后连续)和初始细胞浓度(CultiSpher-S,4×105细胞/ ml)。经证明,微载体是操作CHO-K1细胞产生mAb的标准粘附和悬浮培养物的可行且有利的替代方法,具有操作简单,易于规模化和显着更高水平的mAb产生的优点。然而,不同容器中微载体培养性能的变化重申了在放大过程的每个步骤中都需要进行优化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号